SusanMOttMD

PubMed

• 2 citations
  Consider the bisphosphonate dose.
  Susan M. Ott> ;Journal of Bone and Mineral Research. 2021 Nov 29
• 6 citations
  Importance of bone turnover for therapeutic decisions in patients with CKD-MBD.
  Susan M. Ott, Hartmut H. Malluche, Vanda Jorgetti, Grahame J Elder> ;Kidney International. 2021 Sep 1
• Not etched in bone: the role of osteoclast proton-sensing receptors.
  Susan M. Ott> ;Kidney International. 2021 Mar 1
• In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk.
  Susan M. Ott> ;Annals of Internal Medicine. 2021 Jan 1
• 4 citations
  Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
  Joan C. Lo, Romain Neugebauer, Bruce Ettinger, Malini Chandra, Rita L. Hui, Susan M. Ott, Christopher D. Grimsrud, Monika A Izano> ;BMC Musculoskeletal Disorders. 2020 Dec 3
• 9 citations
  Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women.
  Monika A Izano, Joan C. Lo, Annette L. Adams, Bruce Ettinger, Susan M. Ott, Malini Chandra, Rita L. Hui, Fang Niu, Bonnie H. Li, Romain Neugebauer> ;JAMA Network Open. 2020 Dec 1
• 16 citations
  Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
  , , , , , , , , , , , , , , , , , , > ;Biology of Blood and Marrow Transplantation. 2020 Oct 1
• Structural and Metabolic Assessment of Bone.
  Radhika R. Narla, Susan M. Ott> ;Handbook of Experimental Pharmacology. 2020 Jan 1
• 1 citations
  Determinants of Oral Bisphosphonate Use Beyond 5 Years.
  Monika A Izano, Joan C. Lo, Bruce Ettinger, Susan M. Ott, Bonnie H. Li, Fang Niu, Rita L. Hui, Romain Neugebauer, Annette L. Adams> ;Journal of Managed Care &amp; Specialty Pharmacy. 2020 Feb 3
• 20 citations
  Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.
  Joan C. Lo, Christopher D. Grimsrud, Susan M. Ott, Malini Chandra, Rita L. Hui, Bruce Ettinger> ;Osteoporosis International. 2019 Sep 25
• 2 citations
  Renal insufficiency and bone loss.
  Susan M. Ott> ;Current Opinion in Rheumatology. 2019 Jul 1
• 3 citations
  Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women.
  Monika A Izano, Romain Neugebauer, Bruce Ettinger, Rita Hui, Malini Chandra, Annette L. Adams, Fang Niu, Susan M. Ott, Joan C. Lo> ;Journal of Managed Care &amp; Specialty Pharmacy. 2019 May 28
• 8 citations
  Bones and the sex hormones
  Radhika R. Narla, Susan M. Ott> ;Kidney International. 2018 Aug 1
• Guideline: USPSTF recommends against menopausal estrogen for primary prevention of chronic conditions.
  Susan M. Ott> ;Annals of Internal Medicine. 2018 Mar 20
• 106 citations
  Cortical or Trabecular Bone: What's the Difference?
  Susan M. Ott> ;American Journal of Nephrology. 2018 Jan 1
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women.
  Susan M. Ott> ;Annals of Internal Medicine. 2017 Dec 19
• 30 citations
  The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis.
  Kerensa M. Beekman, Annegreet G Veldhuis-Vlug, Martin den Heijer, Mario Maas, Ania M. Oleksik, Michael W.T. Tanck, Susan M. Ott, Rob van't Hof, Paul Lips, Peter H. Bis...> ;Bone. 2017 Oct 11
• 6 citations
  Review: Osteoporosis drugs may improve BMD and reduce fractures in some patients with CKD.
  Susan M. Ott> ;Annals of Internal Medicine. 2017 Aug 15
• 6 citations
  Renal Osteodystrophy-Time for Common Nomenclature.
  Susan M. Ott> ;Current Osteoporosis Reports. 2017 May 2
• 5 citations
  Long-term bisphosphonates: primum non nocere.
  Susan M. Ott> ;Menopause. 2016 Nov 1
• 15 citations
  Sensitivity and specificity of radiographic characteristics in atypical femoral fractures
  Annette L. Adams, F. Xue, J. Q. Chantra, Richard M. Dell, Susan M. Ott, S. Silverman, J. C. Giaconi, C. Critchlow> ;Osteoporosis International. 2017 Jan 1
• 1 citations
  In postmenopausal women, oral but not transdermal estrogen was associated with increased risk for stroke
  Susan M. Ott> ;Annals of Internal Medicine. 2016 Oct 18
• 8 citations
  Role of proton receptor OGR1 in bone response to metabolic acidosis
  Vanda Jorgetti, Tilman B. Drüeke, Susan M. Ott> ;Kidney International. 2016 Mar 1
• 19 citations
  Bone strength: more than just bone density
  Susan M. Ott> ;Kidney International. 2016 Jan 1
• 9 citations
  Oral contraceptive use and fracture risk around the menopausal transition.
  Delia Scholes, Andrea Z. LaCroix, Rebecca A. Hubbard, Laura Ichikawa, Leslie Spangler, Belinda H. Operskalski, Nancy Gell, Susan M. Ott> ;Menopause. 2016 Feb 1
• Join now to see all